V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008302 | 280005501 | 1.74 | 101 | Palliative (P) | 2014-03-06 | 2014-05-12 | Cisplatin | null | null | 280027032 | CISPLATIN |
| 280008303 | 280005502 | 1.69 | null | Adjuvant (A) | null | 2017-05-20 | CARBOPLATIN + RT | Y | Y | 280027043 | CARBOPLATIN + RT |
| 280008304 | 280005503 | 0 | 95 | Palliative (P) | 2018-03-28 | 2018-03-28 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280027045 | IVA |
| 280008305 | 280005504 | 0 | 45.1 | Adjuvant (A) | 2013-02-28 | 2014-01-20 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280027046 | RMS 2005 TRIAL |
| 280008306 | 280005506 | 1.58 | 78 | Palliative (P) | null | 2017-12-12 | Cetuximab + Radiotherapy Load | 2 | N | 280027050 | CETUXIMAB + RT |
| 280008307 | 280005507 | 1.77 | 72.7 | null | 2016-01-23 | 2016-01-23 | Cisplatin | 2 | N | 280027050 | CISPLATIN |
| 280008308 | 280005507 | 1.62 | 78 | null | 2014-04-09 | 2014-05-10 | Cetuximab + Radiotherapy Maint | N | Y | 280027050 | CETUXIMAB + RT |
| 280008309 | 280005507 | 1.68 | 80.2 | Curative (C) | 2017-03-31 | 2017-05-20 | Cisplatin | 02 | Y | 280027050 | CISPLATIN |
| 280008310 | 280005509 | 1.79 | 11.5 | Palliative (P) | 2016-04-08 | 2016-04-10 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280027084 | PACLITAXEL |
| 280008311 | 280005511 | 1.79 | 77 | null | 2017-10-01 | 2017-11-11 | Cisplatin | N | Y | 280027088 | CISPLATIN |
| 280008312 | 280005511 | 0 | 71 | null | 2014-04-29 | 2014-04-29 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280027088 | IVA |
| 280008313 | 280005511 | 1.87 | 62 | Palliative (P) | 2015-10-06 | 2015-10-20 | Ifosfamide | N | N | 280027088 | IFOSFAMIDE |
| 280008314 | 280005512 | null | 89.2 | Palliative (P) | 2014-05-11 | 2014-05-27 | DOXORUBICIN | null | null | 280027091 | DOXORUBICIN |
| 280008315 | 280005513 | 1.74 | null | Palliative (P) | 2016-08-15 | 2017-01-24 | Cetuximab + Radiotherapy Load | 02 | N | 280027095 | CETUXIMAB + RT |
| 280008316 | 280005514 | 1.75 | 87.7 | Palliative (P) | 2017-12-23 | 2018-01-19 | Cisplatin | N | N | 280027105 | CISPLATIN |
| 280008317 | 280008900 | 1.8 | 72.6 | Curative (C) | 2015-09-28 | 2015-10-24 | Cetuximab + Radiotherapy Maint | N | N | 280027107 | CETUXIMAB + RT |
| 280008318 | 280005515 | 1.27 | null | Disease modification (D) | 2017-12-19 | 2017-12-19 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280027111 | RMS 2005 TRIAL |
| 280008319 | 280005516 | 1.74 | 16 | Curative (C) | 2014-02-09 | 2014-02-09 | CARBOPLATIN + RT | Y | null | 280027112 | CARBOPLATIN + RT |
| 280008320 | 280005517 | 1.78 | 87.7 | Adjuvant (A) | 2015-11-23 | 2015-11-23 | CARBOPLATIN + RT | N | Y | 280027117 | CARBOPLATIN + RT |
| 280008321 | 280005518 | 1.88 | 98 | Palliative (P) | 2016-05-25 | 2016-05-25 | Ifosfamide PVI 1g/m2 14day | N | N | 280027118 | IFOSFAMIDE |
| 280008322 | 280005518 | 1.56 | 32.2 | Palliative (P) | 2017-05-20 | 2017-06-10 | Ifosfamide | N | N | 280027118 | IFOSFAMIDE |
| 280008323 | 280005520 | 1.63 | 76 | Neo-adjuvant (N) | 2016-08-08 | 2016-08-28 | DOXORUBICIN | 02 | N | 280027123 | DOXORUBICIN |
| 280008324 | 280005522 | 1.51 | 79 | Adjuvant (A) | 2013-02-04 | 2013-02-25 | DOXORUBICIN | Y | N | 280027126 | DOXORUBICIN |
| 280008325 | 280011325 | 0 | 74.3 | Palliative (P) | 2016-11-13 | 2016-12-07 | IVA | 02 | Y | 280027134 | IVA |
| 280008326 | 280005524 | 1.68 | 48.1 | Adjuvant (A) | 2017-09-14 | 2017-09-14 | Cisplatin | 02 | Y | 280027139 | CISPLATIN |
| 280008327 | 280005524 | 1.81 | 78.9 | Neo-adjuvant (N) | 2013-10-06 | 2013-10-17 | STS Rhabdo RMS 2005 Vin Cyclo | 1 | N | 280027139 | RMS 2005 TRIAL |
| 280008328 | 280005524 | 0 | 11.3 | Neo-adjuvant (N) | 2013-02-21 | 2013-05-16 | STS Rhabdo RMS 2005 2nd Topo Carbo | N | null | 280027139 | RMS 2005 TRIAL |
| 280008329 | 280005525 | 1.57 | 76.8 | Not known (9) | 2017-04-13 | 2017-04-13 | Paclitaxel 7 day | N | N | 280027148 | PACLITAXEL |
| 280008330 | 280005526 | 1.52 | 47.3 | Curative (C) | 2017-05-06 | 2017-06-27 | STS Rhabdomyosarcoma RMS 2005 IVA | 01 | N | 280027155 | IVA |
| 280008331 | 280005527 | 0.83 | 91 | null | 2018-01-06 | 2018-01-06 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | 280027157 | RMS 2005 TRIAL |
| 280008332 | 280008904 | 1.67 | 86.2 | Palliative (P) | 2016-07-21 | 2016-07-21 | Cisplatin | N | N | 280027162 | CISPLATIN |
| 280008333 | 280005530 | 1.71 | 71 | null | 2014-08-13 | 2014-09-02 | Cetuximab + Radiotherapy Maint | N | Y | 280027168 | CETUXIMAB + RT |
| 280008334 | 280005530 | 1.63 | 64 | Palliative (P) | null | 2015-09-10 | Cetuximab + Radiotherapy Maint | N | N | 280027168 | CETUXIMAB + RT |
| 280008335 | 280005531 | 1.9 | 83.6 | Adjuvant (A) | 2016-05-12 | 2016-05-12 | CARBOPLATIN + RT | null | null | 280027175 | CARBOPLATIN + RT |
| 280008336 | 280005531 | 1.8 | 78.4 | Neo-adjuvant (N) | 2015-10-30 | 2015-10-30 | Paclitaxel (2 or 3 weekly) | null | null | 280027175 | PACLITAXEL |
| 280008337 | 280005533 | 1.67 | null | Palliative (P) | 2013-05-09 | 2013-10-09 | Ifosfamide | N | N | 280027179 | IFOSFAMIDE |
| 280008338 | 280005535 | 1.8 | 92 | Curative (C) | null | 2016-10-21 | Cetuximab + Radiotherapy Maint | 2 | N | 280027181 | CETUXIMAB + RT |
| 280008339 | 280005535 | 0 | null | null | 2017-10-04 | 2018-01-04 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280027181 | IVA |
| 280008340 | 280005538 | 1.6 | 61.1 | Not known (9) | 2016-09-26 | 2016-09-26 | DOXORUBICIN | Y | null | 280027184 | DOXORUBICIN |
| 280008341 | 280005539 | null | 72.6 | Adjuvant (A) | 2017-07-07 | 2017-07-25 | CARBOPLATIN + RT | N | N | 280027195 | CARBOPLATIN + RT |
| 280008342 | 280005539 | 1.56 | 64.4 | Palliative (P) | null | 2016-02-06 | Ifosfamide | null | null | 280027195 | IFOSFAMIDE |
| 280008343 | 280005539 | 1.66 | null | Curative (C) | 2014-11-03 | 2014-11-04 | CARBOPLATIN + RT | N | N | 280027195 | CARBOPLATIN + RT |
| 280008344 | 280005540 | null | 63 | Palliative (P) | 2013-11-07 | 2013-11-29 | Cisplatin | 02 | Y | 280027202 | CISPLATIN |
| 280008345 | 280005541 | 1.81 | 11.1 | Adjuvant (A) | 2015-10-29 | 2015-10-29 | Doxorubicin 75mg/m2 | N | null | 280027206 | DOXORUBICIN |
| 280008346 | 280005545 | 1.72 | 92 | Adjuvant (A) | 2018-05-25 | 2018-06-01 | CARBOPLATIN + RT | Y | Y | 280027208 | CARBOPLATIN + RT |
| 280008347 | 280005545 | null | 64.9 | Adjuvant (A) | 2016-05-22 | 2016-06-01 | CARBOPLATIN + RT | Y | N | 280027208 | CARBOPLATIN + RT |
| 280008348 | 280005545 | 1.6 | 38.4 | Palliative (P) | 2013-03-17 | 2013-06-02 | CETUXIMAB + RT | N | N | 280027208 | CETUXIMAB + RT |
| 280008349 | 280008913 | 1.69 | 52.4 | Palliative (P) | null | 2017-06-12 | Cisplatin 7 day | N | null | 280027221 | CISPLATIN |
| 280008350 | 280005547 | null | 52.4 | Adjuvant (A) | 2017-05-27 | 2017-05-27 | CARBOPLATIN + RT | N | null | 280027222 | CARBOPLATIN + RT |
| 280008351 | 280005547 | 1.57 | 98 | Not known (9) | 2016-10-30 | 2016-10-31 | PACLITAXEL | N | N | 280027222 | PACLITAXEL |